Why pregnancy-test lines cannot verify an hCG vial, how immunoassay units differ from biological potency, and what to request from a laboratory.
A pregnancy test cannot verify the labelled amount, biological potency or overall quality of an hCG vial. A positive line is not a certificate of analysis, and a negative result from a vial preparation is not enough to identify what went wrong.
This guide concerns research-material documentation. It does not validate a supplier, provide a home testing procedure or establish that a research product is suitable for human use.
Home pregnancy tests are qualitative hCG tests: they give a category of result rather than a measured amount per vial. Their intended samples and procedures matter. FDA's device guidance describes testing in biological samples such as urine; it also explains that different immunoassays can recognize different parts of the hCG molecule. FDA hCG test guidance
A preparation made from a research vial is a different sample. The practical implication is that a test's performance in urine cannot simply be assumed to apply to that preparation. Neither a familiar brand nor a visible control line validates the new use.
A supplier's photograph of a positive strip therefore leaves the purchasing question unanswered: does the identified lot meet its stated specification, using a method suitable for that material?
The CDC's NHANES laboratory manual provides a useful concrete example. Its ICON 25 method detects hCG qualitatively in urine at a stated sensitivity of 25 mIU/mL. The manual explicitly separates colour intensity from quantitative measurement: the test cannot determine the numerical hCG concentration or its rate of increase. That is a limitation of the documented method, not a calibration recipe for retail vials. NHANES manual, sections 1.1 and 1.11
Comparing two photographs does not establish that one vial contains twice as much hCG. Repeating a strip test also does not turn it into a validated quantitative assay. For a disputed label claim, ask for a laboratory result that states what was measured and how it relates to the original vial.
A quantitative immunoassay measures hCG through antibody recognition. A bioassay measures activity through a specified biological response. A report must identify which measurement its units describe.
The WHO Sixth International Standard for hCG, NIBSC 18/244, makes this distinction explicit. Its instructions assign 159 IU per ampoule for bioassay and 186 IU per ampoule for immunoassay. Those are assignments for one particular reference material, not interchangeable labels or a universal conversion factor for commercial products. NIBSC instructions, version 4.0, sections 1 and 3
The same instructions warn that suitability as a calibrator for cell-based assays has not been investigated. They also prohibit using its approximate mass content as a formal mass assignment for bioassay calibration. A reference-standard name alone is therefore insufficient: the laboratory needs to explain the standard's suitability for its method and sample.
Use these questions to decide whether the documentation answers the label claim:
| Question | What to request |
|---|---|
| Which material was tested? | Lot number, sample identifier and whether the sample was an unopened finished vial, bulk material or an opened preparation |
| What does the number represent? | Immunoassay result, biological activity, measured mass or chromatographic purity, with its units |
| How was the result calibrated? | Method and reference-standard identification, plus suitability for this formulation |
| Does it describe the original vial? | The laboratory's account of sample preparation, volume and any corrections used to report a per-vial result |
| What remains untested? | Separate coverage for relevant quality questions; do not infer sterility from an hCG measurement |
These are document-review questions, not a complete product-release specification. Use the COA reading guide for purity versus quantity, the sampling guide for what one vial can represent, and the accreditation guide to check the laboratory's scope.
For research procurement, retain the lot and report identifiers and ask the supplier and laboratory to reconcile the claimed amount with a suitable measurement. A strip result cannot resolve that discrepancy or certify the material for use.
The existing hCG supplier listings provide product destinations to which these questions can be applied. That page contains affiliate links; Biomogging may earn a commission from purchases. A listing, purity percentage or testing badge is not independent verification of the vial being considered.
If the result came from your own urine or blood, treat it as a clinical question. Fertility medicines can affect pregnancy-test results, and an unexpected result should be discussed with your healthcare professional. Do not use a personal test result to authenticate a supplier or adjust treatment. MedlinePlus: pregnancy tests
Powered by BTST